MORTIMER IAN sold XENE
March 10, 2026 · Form 4 insider transaction
MORTIMER IAN sold 11,269 shares of Xenon Pharmaceuticals Inc. at $60.11 per share, a transaction worth $677.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
11,269
Price
$60.11
Total value
$677.4K
InsiderMORTIMER IAN
RoleOfficer, Director
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateMarch 10, 2026
Filing dateMarch 11, 2026
Shares owned after14,731
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.